| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2011.637211 |
| P8608 | Fatcat ID | release_7iprvbpkwzad5b5egmfm633itm |
| P698 | PubMed publication ID | 22098403 |
| P2093 | author name string | Svetomir N Markovic | |
| Stephen M Ansell | |||
| Thomas E Witzig | |||
| David J Inwards | |||
| Grzegorz S Nowakowski | |||
| Patrick B Johnston | |||
| Thomas M Habermann | |||
| Joseph P Colgan | |||
| Ryan A Wilcox | |||
| Ivana N M Micallef | |||
| Luis Porrata | |||
| Kay Ristow | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment | Q33931720 | ||
| Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | Q33962334 | ||
| Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model | Q36615128 | ||
| Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies | Q36616736 | ||
| Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols | Q37059428 | ||
| Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. | Q37373035 | ||
| Regulatory myeloid suppressor cells in health and disease | Q37373257 | ||
| Cancer-associated myeloproliferation: old association, new therapeutic target | Q37769017 | ||
| Implications of the tumor microenvironment on survival and disease response in follicular lymphoma | Q37777299 | ||
| M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. | Q39870660 | ||
| The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximab. | Q40137867 | ||
| Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum. | Q40262923 | ||
| Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years | Q43517625 | ||
| Impact of immune parameters on long-term survival in metastatic renal cell carcinoma | Q44811646 | ||
| Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). | Q46525283 | ||
| High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. | Q46845329 | ||
| A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. | Q46972244 | ||
| Revised response criteria for malignant lymphoma | Q47582438 | ||
| Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. | Q51912272 | ||
| The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. | Q53153100 | ||
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. | Q53189779 | ||
| Follicular lymphoma international prognostic index. | Q53289840 | ||
| Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. | Q53338355 | ||
| Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. | Q53366806 | ||
| Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells | Q57279527 | ||
| High serum levels of B-lymphocyte stimulator are associated with clinical?pathological features and outcome in classical Hodgkin lymphoma | Q58883556 | ||
| P433 | issue | 4 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 575-580 | |
| P577 | publication date | 2012-01-03 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. | |
| P478 | volume | 53 |
| Q37416557 | A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma |
| Q92087091 | Absolute Monocyte Count is Superior than Absolute Lymphocyte Count at Day 28 as an Independent Prognostic Factor in Acute Myeloid Leukemia |
| Q53776109 | Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients. |
| Q53088774 | Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages. |
| Q47600079 | Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells |
| Q34798062 | Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma |
| Q34457064 | An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy |
| Q34388117 | Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. |
| Q92200694 | Can the prognosis of mantle cell lymphoma be predicted by simple CBC counts? |
| Q52875256 | Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia. |
| Q40551125 | FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. |
| Q39641273 | High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy |
| Q57801344 | High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy |
| Q89626900 | Immunotherapy of lymphomas |
| Q34952212 | Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma |
| Q90372069 | Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: A cohort study |
| Q38578686 | Myeloid-derived suppressor cells in B cell malignancies. |
| Q38269370 | Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets |
| Q60937764 | Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma |
| Q44404015 | Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era. |
| Q86254777 | Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy |
| Q33662640 | Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma |
| Q41486852 | Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study |
| Q59330044 | Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer |
| Q43114005 | Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis |
| Q48654812 | Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma |
| Q50798505 | Prognostic impact of monocyte count at presentation in mantle cell lymphoma. |
| Q41148150 | Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi. |
| Q37459108 | Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma |
| Q31116522 | Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma |
| Q41002912 | Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism |
| Q48890938 | Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages |
| Q50695373 | Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma. |
| Q40338899 | Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study |
| Q39423479 | Regulatory myeloid cells: an underexplored continent in B-cell lymphomas |
| Q37472823 | Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study |
| Q42237087 | Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. |
| Q43754838 | Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients? |
| Q95267907 | The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review |
| Q36063908 | The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients |
| Q51568489 | The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas. |
| Q85317146 | The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age |
| Q36216519 | The absolute monocyte and lymphocyte prognostic index for patients with diffuse large B-cell lymphoma who receive R-CHOP |
| Q45287423 | The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy. |
| Q50710717 | Unmet needs in the first-line treatment of follicular lymphoma. |
Search more.